TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34787868

Group type: EXPERIMENTAL
Intervention: Logotherapy (10 sessions, 90 min each, twice a week)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine intervention (Control group)
Number of subjects: 40
Study: 35366664

Group type: EXPERIMENTAL
Intervention: Intramuscular pentazocine
Number of subjects: 142

Group type: COMPARATOR
Intervention: Alternating doses of pentazocine and acetaminophen
Number of subjects: 142
Study: 32385598

Group type: EXPERIMENTAL
Intervention: Automated teaching cues in VR training (experimental group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Self-learning without automated teaching (control group)
Number of subjects: 30
Study: 33994021

Group type: EXPERIMENTAL
Intervention: E‐learning assignment on breaking bad news (BBN)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (no E‐learning assignment)
Number of subjects: 160
Study: 34339654

Group type: EXPERIMENTAL
Intervention: Sintilimab plus a bevacizumab biosimilar (IBI305)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sorafenib
Number of subjects: 0
Study: 35007812

Group type: EXPERIMENTAL
Intervention: Immunonutrient formula containing omega‐3‐fatty acids, arginine, dietary nucleotides, and soluble fiber (n = 55)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Isocaloric isonitrogenous control (n = 55)
Number of subjects: 110
Study: 33525480

Group type: EXPERIMENTAL
Intervention: Non‐green stalks (NGS)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Multicolored stalks (MS)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Green stalks (GS)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Green leaves (GL)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Multicolored leaves (ML)
Number of subjects: 300
Study: 32719274

Group type: EXPERIMENTAL
Intervention: Adaptive radiotherapy (ART)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional intensity-modulated radiotherapy (IMRT)
Number of subjects: 60
Study: 34535238

Group type: EXPERIMENTAL
Intervention: Hyperangulated video laryngoscopy (HAVL)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard geometry video laryngoscopy (SGVL)
Number of subjects: 15
Study: 32535566

Group type: EXPERIMENTAL
Intervention: CITO-STOP
Number of subjects: 55

Group type: COMPARATOR
Intervention: Standard hygienic technique
Number of subjects: 55
Study: 33902293

Group type: EXPERIMENTAL
Intervention: Bach flower remedies (BFR) - 30% hydro-brandy solution with two drops each of Impatiens, White Chestnut, Cherry Plum, Chicory, Crab Apple, and Pine, orally ingested (4 drops, 4 times a day for 4 weeks)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Bach flower remedies (BFR)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 33595680

Group type: EXPERIMENTAL
Intervention: Intervention group (specific treatment not detailed)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (specific treatment not detailed)
Number of subjects: 42
Study: 32248846

Group type: EXPERIMENTAL
Intervention: Maximal eating (until 'could not eat another bite')
Number of subjects: 14

Group type: COMPARATOR
Intervention: Ad libitum eating (until 'comfortably full')
Number of subjects: 14
Study: 35820629

Group type: EXPERIMENTAL
Intervention: KL130008 (1–20 mg single doses or 2–6 mg multiple doses once daily for seven days)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: KL130008
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 34548526

Group type: EXPERIMENTAL
Intervention: Individually calculated loading regimen (weekly capsules)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Monthly drinking solution (24,000 IU vitamin D)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Monthly capsules (24,000 IU vitamin D)
Number of subjects: 52
Study: 35785880

Group type: EXPERIMENTAL
Intervention: Full face mask
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oronasal mask
Number of subjects: 60
Study: 32389453

Group type: EXPERIMENTAL
Intervention: Remifentanil effect-site concentration 1 ng/mL
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Remifentanil effect-site concentration 2 ng/mL
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Remifentanil effect-site concentration 3 ng/mL
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 73
Study: 32540878

Group type: EXPERIMENTAL
Intervention: Needle tip tracking
Number of subjects: 26

Group type: COMPARATOR
Intervention: No needle tip tracking (control)
Number of subjects: 26
Study: 33568076

Group type: EXPERIMENTAL
Intervention: Good knowledge about cataract
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Age (≥40 years)
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Elementary school completed
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: High school & above
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Governmental and non-governmental employed
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Merchant
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Positive Attitude
Number of subjects: 599

Group type: COMPARATOR
Intervention: Rural residence
Number of subjects: 599
Study: 33720787

Group type: EXPERIMENTAL
Intervention: One-on-one PRISM-P intervention
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Group PRISM-P intervention
Number of subjects: 94

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 94
Study: 32977595

Group type: EXPERIMENTAL
Intervention: 3-week intensive diet-exercise intervention (Phase 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Free living conditions supervision (Phase 2)
Number of subjects: 0
Study: 35637457

Group type: EXPERIMENTAL
Intervention: Lung ultrasonography (US)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Fiberoptic bronchoscopy (FOB)
Number of subjects: 200
Study: 35275165

Group type: EXPERIMENTAL
Intervention: Dexamethasone (exposed group)
Number of subjects: 828

Group type: EXPERIMENTAL
Intervention: Prednisolone or Methylprednisolone (exposed group)
Number of subjects: 828

Group type: COMPARATOR
Intervention: Control group (unexposed infants)
Number of subjects: 828
Study: 34331551

Group type: EXPERIMENTAL
Intervention: Indobufen 100 mg twice daily for 1 month
Number of subjects: 238

Group type: COMPARATOR
Intervention: Aspirin 100 mg once daily
Number of subjects: 238

Group type: COMPARATOR
Intervention: Aspirin 50 mg twice daily, 75 mg once daily, 50 mg once daily
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Indobufen 100 mg twice daily
Number of subjects: 238

Group type: COMPARATOR
Intervention: Aspirin given every second or third day
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: All treatment regimens
Number of subjects: 238
Study: 33321007

Group type: EXPERIMENTAL
Intervention: Appetite-conditioned reflex stimulation (visual, nasal, taste, and hearing stimulation)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Appetite-conditioned reflex stimulation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (standard early enteral nutrition)
Number of subjects: 70
Study: 33781724

Group type: EXPERIMENTAL
Intervention: Fresh corneal graft carrier
Number of subjects: 19

Group type: COMPARATOR
Intervention: Frozen corneal graft carrier
Number of subjects: 19
Study: 32892250

Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD)
Number of subjects: 74
Study: 33212271

Group type: EXPERIMENTAL
Intervention: Geographic atrophy area in the central 1-mm diameter zone
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: GA area in the temporal region
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: GA area in the superior region
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: VA decline rate in eyes with initial noncentral GA
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: VA decline rate in eyes with initial central GA
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Total GA area
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: GA area in the central zone
Number of subjects: 365
Study: 32166994

Group type: EXPERIMENTAL
Intervention: Treosulfan-based regimens
Number of subjects: 34

Group type: COMPARATOR
Intervention: Cyclophosphamide (Cy)-total body irradiation (TBI)-based regimens
Number of subjects: 34
Study: 35597471

Group type: EXPERIMENTAL
Intervention: Vortioxetine (5-20 mg/day)
Number of subjects: 5982
Study: 33358648

Group type: EXPERIMENTAL
Intervention: MANTA VCD (Teleflex)
Number of subjects: 210

Group type: COMPARATOR
Intervention: ProGlide (Abbott Vascular)
Number of subjects: 210
Study: 32616272

Group type: EXPERIMENTAL
Intervention: 20L:4D
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: 18L:6D
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: 16L:8D
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: 12L:12D
Number of subjects: 432
Study: 35209877

Group type: EXPERIMENTAL
Intervention: SMART Choice tool
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 0
Study: 34488408

Group type: EXPERIMENTAL
Intervention: Six-month anti-TB therapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nine-month anti-TB therapy
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 35892319

Group type: EXPERIMENTAL
Intervention: Robot-assisted training
Number of subjects: 172

Group type: COMPARATOR
Intervention: Enhanced upper extremity therapy
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 172
Study: 33360679

Group type: EXPERIMENTAL
Intervention: ASK120067 (oral irreversible tyrosine kinase inhibitor)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ASK120067 (oral administration)
Number of subjects: 0
Study: 35413023

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 33788609

Group type: EXPERIMENTAL
Intervention: Drug therapies (acetaminophen, NSAIDs, opioids, benzodiazepines, Gabapentin, Neurontin, cortisone injections)
Number of subjects: 545

Group type: EXPERIMENTAL
Intervention: Nondrug therapies (self-care treatments, massage, acupuncture, spinal manipulation, physical therapy)
Number of subjects: 545

Group type: EXPERIMENTAL
Intervention: Overall treatment recommendations
Number of subjects: 545

Group type: EXPERIMENTAL
Intervention: Adherence to treatment recommendations
Number of subjects: 545
Study: 35160276

Group type: EXPERIMENTAL
Intervention: Carbohydrate-enriched drink (NutriciaTM Pre-op®) 400 mL
Number of subjects: 100

Group type: COMPARATOR
Intervention: Fasting (Control group)
Number of subjects: 100
Study: 32842315

Group type: EXPERIMENTAL
Intervention: 250 μg of CpG ODN recombinant (Hansenula polymorpha) Hepatitis B vaccine
Number of subjects: 48

Group type: COMPARATOR
Intervention: 10 μg of commercial Hepatitis B vaccine
Number of subjects: 48
Study: 36233749

Group type: EXPERIMENTAL
Intervention: Bilateral anodal tDCS (20-min session, 1.5 mA, 3 times a week for 2 weeks)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (tDCS current delivered for 30 seconds)
Number of subjects: 84
Study: 35229141

Group type: EXPERIMENTAL
Intervention: Olaparib
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control (abiraterone or enzalutamide)
Number of subjects: 101
Study: 32669957

Group type: EXPERIMENTAL
Intervention: ERAS protocol
Number of subjects: 129

Group type: COMPARATOR
Intervention: Conventional postoperative care regimen
Number of subjects: 129
Study: 33806310

Group type: EXPERIMENTAL
Intervention: Daratumumab added to standard of care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daratumumab alone or as part of combination regimens
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study: 34787471

Group type: EXPERIMENTAL
Intervention: Qualitative analysis of burdens of participation in a clinical trial for advanced melanoma patients.
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Factors influencing capacity to cope with trial burdens.
Number of subjects: 14
Study: 34418903

Group type: EXPERIMENTAL
Intervention: Melatonin (6 mg orally for 2 weeks, taken half an hour before bedtime in low light conditions)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control (regular medications)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 31
Study: 32403158

Group type: EXPERIMENTAL
Intervention: Suprapubic externalized single J stents (N = 100)
Number of subjects: 200

Group type: COMPARATOR
Intervention: No stent (N = 100)
Number of subjects: 200
Study: 36202129

Group type: EXPERIMENTAL
Intervention: Enhanced usual care plus psychosocial intervention (17-week program based on psychoeducation and behavioral activation)
Number of subjects: 715

Group type: COMPARATOR
Intervention: Enhanced usual care (control group)
Number of subjects: 715
Study: 32909274

Group type: EXPERIMENTAL
Intervention: Gene-panel next-generation sequencing (NGS) (32–55 genes)
Number of subjects: 296

Group type: COMPARATOR
Intervention: Sanger sequencing (one to four genes)
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 296
Study: 33025372

Group type: EXPERIMENTAL
Intervention: Group intervention combining self-hypnosis and self-care
Number of subjects: 95

Group type: COMPARATOR
Intervention: Wait-list control group (WLCG)
Number of subjects: 95
Study: 33249881

Group type: EXPERIMENTAL
Intervention: Increasing DBP increments
Number of subjects: 47407

Group type: EXPERIMENTAL
Intervention: Non-linear MR analyses
Number of subjects: 47407
Study: 35965311

Group type: EXPERIMENTAL
Intervention: Novel control mechanism using electromyography surface sensors applied to temporalis muscles
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Clinical Global Impression of Change survey
Number of subjects: 4
Study: 32251176

Group type: EXPERIMENTAL
Intervention: Aspirin (81 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 36483298

Group type: EXPERIMENTAL
Intervention: Virtual Reality Training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (Physical Education Course)
Number of subjects: 30
Study: 32593936

Group type: EXPERIMENTAL
Intervention: Endometrial scratch injury (ESI) via office hysteroscopy
Number of subjects: 184

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 184
Study: 34705072

Group type: EXPERIMENTAL
Intervention: Single dose of PRP (n: 62)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Three doses of PRP (n: 63)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Single dose of sodium saline (NS) (n: 59)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Three doses of sodium saline (NS) (n: 53)
Number of subjects: 237
Study: 33955231

Group type: EXPERIMENTAL
Intervention: NT-proBNP goal achievement in women
Number of subjects: 894

Group type: EXPERIMENTAL
Intervention: NT-proBNP goal achievement in men
Number of subjects: 894
Study: 32928185

Group type: EXPERIMENTAL
Intervention: Physical activity intervention with supporting materials
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Physical activity intervention with access to support groups
Number of subjects: 17

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 17
Study: 36175102

Group type: EXPERIMENTAL
Intervention: One anastomosis gastric bypass (OAGB)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: OAGB
Number of subjects: 248

Group type: COMPARATOR
Intervention: RYGB
Number of subjects: 248
Study: 33579594

Group type: EXPERIMENTAL
Intervention: Doctor shopping
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Pharmacy shopping
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Dosage
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Concomitant benzodiazepine use
Number of subjects: 87
Study: 36210434

Group type: EXPERIMENTAL
Intervention: Differentiated digital intervention (ART medication messages, medication reminders, peer education, online discussion)
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: One-to-one instant message-based intervention
Number of subjects: 576

Group type: COMPARATOR
Intervention: Control arm (messages on health behavior and nutrition)
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Overall intervention
Number of subjects: 576
Study: 32813124

Group type: EXPERIMENTAL
Intervention: Chest shielding (using food grade aluminium foil on the left side of the chest during phototherapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chest shielding
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 35157963

Group type: EXPERIMENTAL
Intervention: MPFL reconstruction
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: MQTFL reconstruction
Number of subjects: 8

Group type: COMPARATOR
Intervention: MPFC-deficient control state
Number of subjects: 8
Study: 34114132

Group type: EXPERIMENTAL
Intervention: DEMQOL
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: DEMQOL-U
Number of subjects: 490
Study: 32652799

Group type: EXPERIMENTAL
Intervention: High-protein diet (30E% protein)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Low-protein diet (10E% protein)
Number of subjects: 19
Study: 36046209

Group type: EXPERIMENTAL
Intervention: Sangdantongluo granule
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study: 34543722

Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR) targeting a 25% reduction in energy intake
Number of subjects: 144

Group type: COMPARATOR
Intervention: Ad libitum (AL) control group
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: FTO rs9939609 SNP
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: FTO rs9939609 SNP in AAs
Number of subjects: 144
Study: 34134469

Group type: EXPERIMENTAL
Intervention: Extended maintenance with subcutaneous rituximab, n=138
Number of subjects: 692

Group type: COMPARATOR
Intervention: Observation only, n=138
Number of subjects: 692
Study: 32761890

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 1200
Study: 35979052

Group type: EXPERIMENTAL
Intervention: Continuous nutrition management intervention based on mobile medical APP
Number of subjects: 80
Study: 33601718

Group type: EXPERIMENTAL
Intervention: HF-rTMS over the right dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation over the right dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 0
Study: 36156932

Group type: EXPERIMENTAL
Intervention: Peroral endoscopic myotomy (POEM)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Laparoscopic myotomy and partial fundoplication (LM-PF)
Number of subjects: 40
Study: 33782116

Group type: EXPERIMENTAL
Intervention: Exposure to left-leaning media (HuffPost)
Number of subjects: 1037

Group type: EXPERIMENTAL
Intervention: Exposure to right-leaning media (Fox News)
Number of subjects: 1037

Group type: EXPERIMENTAL
Intervention: Both treatments (left-leaning and right-leaning media)
Number of subjects: 1037
Study: 34176293

Group type: EXPERIMENTAL
Intervention: Highest tertile of systolic blood pressure variability (BPV)
Number of subjects: 19114
Study: 32641226

Group type: EXPERIMENTAL
Intervention: Sacubitril/Valsartan (S/V) titrated to 97 mg/103 mg twice daily
Number of subjects: 400

Group type: COMPARATOR
Intervention: Valsartan 160 mg twice daily
Number of subjects: 400
Study: 35146554

Group type: EXPERIMENTAL
Intervention: Proficiency-based VR training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Repetition-based VR training
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Total cohort (both groups)
Number of subjects: 22
Study: 34496085

Group type: EXPERIMENTAL
Intervention: Postoperative antibiotics (2g amoxicillin preoperatively and 500mg tid for 7 days postoperatively)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (same preoperative dose of amoxicillin and placebo postoperatively)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Postoperative pain severity assessment
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Implant survival rate
Number of subjects: 38
Study: 33248858

Group type: EXPERIMENTAL
Intervention: Exoskeleton-assisted walking
Number of subjects: 6

Group type: COMPARATOR
Intervention: Unassisted walking
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Exoskeleton training
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Post-training walking with the exoskeleton
Number of subjects: 6
Study: 32224896

Group type: EXPERIMENTAL
Intervention: Paclitaxel-Cisplatin (80 mg/m2 weekly + 20 mg/m2 triweekly cisplatin)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Paclitaxel-Carboplatin (80 mg/m2 weekly + AUC 5 triweekly carboplatin)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Paclitaxel-Carboplatin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Paclitaxel-Cisplatin and Paclitaxel-Carboplatin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Chemotherapy duration >21 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Suboptimal debulking surgery (>1 cm)
Number of subjects: 40
Study: 35833082

Group type: EXPERIMENTAL
Intervention: Modified Xiaochaihu Decoction combined with mirtazapine
Number of subjects: 64

Group type: COMPARATOR
Intervention: Modified Xiaochaihu Decoction (control group)
Number of subjects: 64
Study: 33183752

Group type: EXPERIMENTAL
Intervention: N-Hexyl Cyanoacrylate glue
Number of subjects: 58

Group type: COMPARATOR
Intervention: Sutures
Number of subjects: 58
Study: 36401493

Group type: EXPERIMENTAL
Intervention: ORi-SpO2 group (FiO2 adjusted to target 0 < 0 ORi < .3 and SpO2 ≥ 98%)
Number of subjects: 62

Group type: COMPARATOR
Intervention: SpO2 group (FiO2 adjusted to target SpO2 ≥ 98%)
Number of subjects: 62

Group type: COMPARATOR
Intervention: SpO2 group
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: ORi-SpO2 group
Number of subjects: 62
Study: 32717868

Group type: EXPERIMENTAL
Intervention: Vigorous-intensity physical exercise program (2 hours per week)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control Group (no intervention)
Number of subjects: 98
Study: 36441999

Group type: EXPERIMENTAL
Intervention: Two Families Now (TFN) or Children in Between (CIB)
Number of subjects: 221

Group type: COMPARATOR
Intervention: No-program control group
Number of subjects: 221
Study: 34009517

Group type: EXPERIMENTAL
Intervention: High-Intensity Focused Ultrasound (HIFU)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Micropulse Cyclophotocoagulation (MP-CPC)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Transscleral Continuous-Wave Cyclophotocoagulation (CW-CPC)
Number of subjects: 30